Top barriers to patient persistence

Physician time constraints, competing priorities for patients and shortcomings in follow-up initiatives are a few of the top causes of medication non-adherence; a $300 billion source of wasted U.S. healthcare spending every year. What can pharma brand teams do to improve patient persistence? It begins with an honest assessment of the patient journey and optimization… read more

Pharma: Meet Your New Neighbors

Executives from patient care, diagnostics, payer and pharma companies converge to share the inside scoop on outcomes-based contracting Curant Health’s COO, Marc O’Connor, recently participated on a panel held at the CBI Outcomes-Based Contracting conference in Philadelphia. Marc was joined on the panel by speakers Harry Vargo of Aetna and Sachin Kamal-Bahl of Pfizer, along… read more

Removing Barriers and Finding Solutions for Non-adherent HIV-Positive Patients: A Care Management Patient Success Story

Curant Health has partnered with Chattanooga Cares to offer a highly coordinated program of clinical services, reporting, and analytics.

Insights From A Bustling 340B Winter Conference

This year’s 340B Winter Conference was bursting at the seams with attendees. There were over 1,630 registrants for the conference representing a 12% growth over last year’s numbers. It was standing room only in the “340B Lessons from the Field” sessions led by many of our covered entity partners. In fact, there is so much… read more

What does it take to improve outcomes advocacy? Introducing the PEER Model

Once a prescription is written – just one part of the brand adoption challenge – pharmaceutical manufacturers are limited in their ability to influence patient compliance and persistence. For years, pharma manufacturers have struggled to influence change in the 20-30 percent of prescriptions that never get filled and the estimated 50 percent of patients who… read more

From Washington, DC to your clinic’s front door: what will we learn together at the 2018 340B Coalition Winter Conference?

Now more than ever, 340B covered entities must ensure they are providing high value, critical care for underserved populations in a way that stands up to scrutiny. What will we learn at 340B Winter 2018?

Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or